ReviewTherapeutics and clinical risk management2016

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far.

Yijun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.